Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: TheBodyPRO.com Covers AIDS 2014
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Medical News

Anemia Drug May Be Useful in Treatment of AIDS-Related Dementia

July 9, 2004

The anemia drug erythropoietin, which is sold by Amgen as Epogen and Aranesp and by Johnson & Johnson as Procrit and Eprex, may be used to treat AIDS-related dementia, the New York Times reports. Dr. Stuart Lipton, scientific director of the San Diego, Calif.-based Burnham Institute's Del E. Webb Center for Neurosciences and Aging, has formed a company called NeuroMolecular and is planning to begin a clinical trial using EPO to treat the illness. Treating people who are not anemic with EPO typically is risky because the drug increases the amount of red blood cells in the patient's system to potentially dangerous levels. However, because HIV-positive people are often anemic the increase in red blood cell levels "would not be a problem," Lipton said, according to the Times (Pollack, New York Times, 7/9).

Back to other news for July 9, 2004


Reprinted with permission from kaisernetwork.org. You can view the entire Kaiser Daily HIV/AIDS Report, search the archives, or sign up for email delivery at www.kaisernetwork.org/dailyreports/hiv. The Kaiser Daily HIV/AIDS Report is published for kaisernetwork.org, a free service of the Kaiser Family Foundation, by The Advisory Board Company. © 2004 by The Advisory Board Company and Kaiser Family Foundation. All rights reserved.


Related Stories

More HIV News


  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily HIV/AIDS Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
 

Tools
 

Advertisement